Anaesthetic efficacy and influence on cardiovascular parameters change of intraosseous computerised anaesthesia versus inferior alveolar nerve block anaesthesia in acute irreversible pulpitis of mandibular molars: study protocol for a prospective randomised controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
05 Dec 2022
Historique:
received: 12 05 2022
accepted: 11 11 2022
entrez: 6 12 2022
pubmed: 7 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Irreversible pulpitis is a highly painful inflammatory condition of the dental pulp. The recommended care is the removal of the coronal pulp (pulpotomy) for emergency treatment in multi-rooted teeth. However, achieving adequate analgesia in the case of mandibular molars presents many difficulties according to the dental literature. Intraosseous computerised anaesthesia (ICA), in particular, the QuickSleeper™ system, has already been demonstrated to be clinically efficient, but ICA is known to increase the heart rate reversibly in a manner that depends on the speed of injection. Therefore, accelerated heart rate was examined as a potential adverse effect of this injection. This trial aims to compare the cardiovascular effects and the anaesthetic efficacy of ICA versus inferior alveolar nerve block anaesthesia (IANB) in acute irreversible pulpitis of mandibular molars. This study is a non-inferiority prospective, randomised, controlled, single-blind, two-group trial conducted at the Nantes University Hospital. The study design included two parallel arms at a ratio of 1:1 that will allocate seventy-two patients into two groups: the first group will receive QuickSleeper™ intraosseous anaesthesia; the second will receive an inferior alveolar nerve block before emergency treatment (pulpotomy). This study will include patients requiring emergency dental care under local anaesthesia with confirmed irreversible pulpitis in mandibular molars. The primary outcome is the time taken for the fluctuations in the cardiovascular parameters to return to baseline values during endodontic treatment in two different anaesthetic techniques. The secondary outcomes include efficacy of the technique, patient's pain perception before and after care, any post-operative effects, and factors associated with the delay of recovery of cardiovascular parameters between the 2 anaesthetic techniques. This trial will evaluate the factors associated with heart rate increase during local anaesthesia administration. The use of blood pressure and cardiovascular measurements can be considered an asset and additional safety in managing local anaesthesia. Detecting early signs of potential adverse events (AEs), particularly patients with certain medical conditions (cardiac rhythm disorders), would suggest caution in administering anaesthesia. ClinicalTrials.gov ID: NCT03802305 registered January 14, 2019. (version no. 1.2; 5 November 2021).

Sections du résumé

BACKGROUND BACKGROUND
Irreversible pulpitis is a highly painful inflammatory condition of the dental pulp. The recommended care is the removal of the coronal pulp (pulpotomy) for emergency treatment in multi-rooted teeth. However, achieving adequate analgesia in the case of mandibular molars presents many difficulties according to the dental literature. Intraosseous computerised anaesthesia (ICA), in particular, the QuickSleeper™ system, has already been demonstrated to be clinically efficient, but ICA is known to increase the heart rate reversibly in a manner that depends on the speed of injection. Therefore, accelerated heart rate was examined as a potential adverse effect of this injection. This trial aims to compare the cardiovascular effects and the anaesthetic efficacy of ICA versus inferior alveolar nerve block anaesthesia (IANB) in acute irreversible pulpitis of mandibular molars.
METHODS METHODS
This study is a non-inferiority prospective, randomised, controlled, single-blind, two-group trial conducted at the Nantes University Hospital. The study design included two parallel arms at a ratio of 1:1 that will allocate seventy-two patients into two groups: the first group will receive QuickSleeper™ intraosseous anaesthesia; the second will receive an inferior alveolar nerve block before emergency treatment (pulpotomy). This study will include patients requiring emergency dental care under local anaesthesia with confirmed irreversible pulpitis in mandibular molars. The primary outcome is the time taken for the fluctuations in the cardiovascular parameters to return to baseline values during endodontic treatment in two different anaesthetic techniques. The secondary outcomes include efficacy of the technique, patient's pain perception before and after care, any post-operative effects, and factors associated with the delay of recovery of cardiovascular parameters between the 2 anaesthetic techniques.
DISCUSSION CONCLUSIONS
This trial will evaluate the factors associated with heart rate increase during local anaesthesia administration. The use of blood pressure and cardiovascular measurements can be considered an asset and additional safety in managing local anaesthesia. Detecting early signs of potential adverse events (AEs), particularly patients with certain medical conditions (cardiac rhythm disorders), would suggest caution in administering anaesthesia.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov ID: NCT03802305 registered January 14, 2019. (version no. 1.2; 5 November 2021).

Identifiants

pubmed: 36471427
doi: 10.1186/s13063-022-06915-4
pii: 10.1186/s13063-022-06915-4
pmc: PMC9720960
doi:

Substances chimiques

Anesthetics, Local 0
Lidocaine 98PI200987

Banques de données

ClinicalTrials.gov
['NCT03802305']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

979

Subventions

Organisme : UFR odontologie Nantes
ID : UFRODONTO2019/

Informations de copyright

© 2022. The Author(s).

Références

J Can Dent Assoc. 2001 Jul-Aug;67(7):391-7
pubmed: 11468097
J Am Dent Assoc. 1999 May;130(5):649-57
pubmed: 10332129
Int Endod J. 2012 Oct;45(10):921-6
pubmed: 22506833
Aust Endod J. 2000 Apr;26(1):10-4
pubmed: 11359291
Oral Surg Oral Med Oral Pathol. 1985 May;59(5):517-21
pubmed: 3859810
J Endod. 2005 Jun;31(6):435-8
pubmed: 15917682
J Anaesthesiol Clin Pharmacol. 2011 Oct;27(4):438-9
pubmed: 22096273
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Dec;84(6):676-82
pubmed: 9431539
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov;114(5 Suppl):S132-9
pubmed: 23063389
Int Endod J. 2002 Nov;35(11):885-96
pubmed: 12453016
J Conserv Dent. 2015 May-Jun;18(3):182-6
pubmed: 26069400
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jun;81(6):634-41
pubmed: 8784893
Int Endod J. 2018 Apr;51 Suppl 3:e227-e237
pubmed: 28857203
J Endod. 2014 Jun;40(6):753-8
pubmed: 24862701
J Endod. 2008 Apr;34(4):438-41
pubmed: 18358891
J Endod. 1989 Jun;15(6):254-6
pubmed: 2592880
J Endod. 2015 Jan;41(1):33-5
pubmed: 25442722
Oral Surg Oral Med Oral Pathol. 1977 Jun;43(6):948-53
pubmed: 266686
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jul;98(1):124-31
pubmed: 15243483
Arch Oral Biol. 1991;36(2):147-53
pubmed: 2059163
J Calif Dent Assoc. 2003 May;31(5):388-96
pubmed: 12839231
Anesth Prog. 2008 Spring;55(1):9-15
pubmed: 18327970
J Endod. 2009 Feb;35(2):165-8
pubmed: 19166765
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
J Am Dent Assoc. 1984 Feb;108(2):205-8
pubmed: 6584494
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Aug;116(2):e85-91
pubmed: 22841432
Oral Surg Oral Med Oral Pathol. 1992 Apr;73(4):479-83
pubmed: 1574311
Oral Surg Oral Med Oral Pathol. 1975 Nov;40(5):574-83
pubmed: 1059057
J Endod. 2008 Feb;34(2):126-30
pubmed: 18215666
J Endod. 2009 Jul;35(7):925-9
pubmed: 19567309
J Endod. 1996 Sep;22(9):481-6
pubmed: 9198431
J Am Dent Assoc. 1978 Nov;97(5):816-9
pubmed: 31377
J Endod. 2004 Aug;30(8):568-71
pubmed: 15273637

Auteurs

Amany Laham (A)

Nantes Université, CHU Nantes, Unité d'Investigation Clinique en Odontologie, UIC 11, F-44000, Nantes, France.

Roselyne Clouet (R)

Nantes Université, CHU Nantes, F-44000, Nantes, France.

Gilles Amador Del Valle (GA)

Nantes Université, CHU Nantes, Unité d'Investigation Clinique en Odontologie, UIC 11, F-44000, Nantes, France.

Alexis Gaudin (A)

Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229, F-44000, Nantes, France. alexis.gaudin@univ-nantes.fr.

Tony Prud'homme (T)

Nantes Université, CHU Nantes, Unité d'Investigation Clinique en Odontologie, UIC 11, F-44000, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH